Specialized RWD for Research and Personalized Medicine
With specialization in chronic diseases, OM1 is a leading real-world data, outcomes and technology company leveraging big clinical data and AI to better understand, compare, and predict patient outcomes.
Our specialized, prospective, linked datasets include RA, SLE, MS, HF, ENT, AD, PsO, PsA, MDD, and more. We also connect and normalize networks of data to build automated, custom cohorts and registries in other conditions, such as oncology and rare diseases.
OM1’s Artificial Intelligence (AI) platform can help you target specialized patient populations and to find patients most likely to have undiagnosed disease or higher risk.